Chun‐Wen Su

628 total citations
24 papers, 486 citations indexed

About

Chun‐Wen Su is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chun‐Wen Su has authored 24 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Chun‐Wen Su's work include RNA modifications and cancer (5 papers), Cell death mechanisms and regulation (4 papers) and Peptidase Inhibition and Analysis (4 papers). Chun‐Wen Su is often cited by papers focused on RNA modifications and cancer (5 papers), Cell death mechanisms and regulation (4 papers) and Peptidase Inhibition and Analysis (4 papers). Chun‐Wen Su collaborates with scholars based in Taiwan and United States. Chun‐Wen Su's co-authors include Shun‐Fa Yang, Chiao‐Wen Lin, Wei‐En Yang, Mu‐Kuan Chen, Chun‐Yi Chuang, Yu‐Fan Liu, Shih‐Chi Su, Shih‐Chi Su, Yih‐Shou Hsieh and Wen‐Hung Chung and has published in prestigious journals such as International Journal of Molecular Sciences, Medicine and Food and Chemical Toxicology.

In The Last Decade

Chun‐Wen Su

23 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Wen Su Taiwan 13 316 168 101 51 40 24 486
Renqiang Ma China 15 272 0.9× 144 0.9× 115 1.1× 121 2.4× 111 2.8× 45 605
Yuhei Takada Japan 5 209 0.7× 121 0.7× 60 0.6× 116 2.3× 20 0.5× 8 396
Rodolfo Chavez-Dominguez Mexico 6 288 0.9× 142 0.8× 119 1.2× 90 1.8× 44 1.1× 12 562
Binbin Yu China 15 374 1.2× 224 1.3× 126 1.2× 36 0.7× 95 2.4× 36 585
Nashwa Kabil United States 12 307 1.0× 155 0.9× 147 1.5× 88 1.7× 38 0.9× 19 540
Jung‐Yu Kan Taiwan 15 341 1.1× 226 1.3× 138 1.4× 60 1.2× 74 1.9× 29 561
Zumin Xu China 13 294 0.9× 141 0.8× 109 1.1× 44 0.9× 47 1.2× 24 427
Cuijuan Qian China 13 300 0.9× 141 0.8× 89 0.9× 24 0.5× 34 0.8× 25 406

Countries citing papers authored by Chun‐Wen Su

Since Specialization
Citations

This map shows the geographic impact of Chun‐Wen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Wen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Wen Su more than expected).

Fields of papers citing papers by Chun‐Wen Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Wen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Wen Su. The network helps show where Chun‐Wen Su may publish in the future.

Co-authorship network of co-authors of Chun‐Wen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Wen Su. A scholar is included among the top collaborators of Chun‐Wen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Wen Su. Chun‐Wen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Chun‐Yi, et al.. (2025). Genetic associations of Neat1 polymorphisms with clinicopathologic characteristics of tongue cancer. International Journal of Medical Sciences. 22(5). 1208–1214.
2.
Su, Shih‐Chi, Chiao‐Wen Lin, Mu-Kuan Chen, et al.. (2025). Multimodal profiling of oral squamous cell carcinoma identifies genomic alterations and expression programs associated with betel quid chewing. Neoplasia. 68. 101218–101218. 1 indexed citations
3.
Lu, Hsueh‐Ju, Chun‐Wen Su, Shih‐Chi Su, et al.. (2024). Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma. Oral Diseases. 31(3). 769–781. 2 indexed citations
4.
Lin, Chiao‐Wen, Wei‐En Yang, Chun‐Wen Su, et al.. (2024). IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through Src-mediated upregulation of EREG in oral cancer. International Journal of Biological Sciences. 20(3). 818–830. 14 indexed citations
5.
Hsu, Hui‐Ting, Yi‐Tzu Chen, Chun‐Wen Su, et al.. (2024). Impact of LINC00312 gene polymorphism coupled with habitual risks on buccal mucosa cancer. Journal of Cancer. 15(8). 2354–2360. 2 indexed citations
6.
Yang, Wei‐En, Yi‐Tzu Chen, Chun‐Wen Su, et al.. (2023). Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK/HO‐1 pathway activation. Journal of Cellular and Molecular Medicine. 27(9). 1250–1260. 11 indexed citations
7.
Hua, Chun‐Hung, Chun‐Yi Chuang, Chun‐Wen Su, et al.. (2023). Analysis of MUC6 polymorphisms on the clinicopathologic characteristics of Asian patients with oral squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 27(17). 2594–2602. 2 indexed citations
8.
Chuang, Chun‐Yi, Chiao‐Wen Lin, Chun‐Wen Su, et al.. (2022). Deoxyshikonin Mediates Heme Oxygenase-1 Induction and Apoptotic Response via p38 Signaling in Tongue Cancer Cell Lines. International Journal of Molecular Sciences. 23(13). 7115–7115. 5 indexed citations
10.
Su, Shih‐Chi, Yi‐Tzu Chen, Yi‐Hsien Hsieh, et al.. (2022). Gambogic Acid Induces HO-1 Expression and Cell Apoptosis through p38 Signaling in Oral Squamous Cell Carcinoma. The American Journal of Chinese Medicine. 50(6). 1663–1679. 8 indexed citations
11.
Chen, Yi‐Tzu, Chiao‐Wen Lin, Chun‐Wen Su, et al.. (2021). Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways. Biomedicines. 9(10). 1295–1295. 15 indexed citations
12.
Su, Chun‐Wen, Chun‐Yi Chuang, Yi‐Tzu Chen, et al.. (2021). FLLL32 Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells by Regulating the p38 Pathway. International Journal of Molecular Sciences. 22(21). 11860–11860. 19 indexed citations
13.
Su, Chun‐Wen, et al.. (2020). Carbonic Anhydrase III Promotes Cell Migration and Epithelial–Mesenchymal Transition in Oral Squamous Cell Carcinoma. Cells. 9(3). 704–704. 20 indexed citations
14.
Su, Chun‐Wen, et al.. (2018). Functional variant of CHI3L1 gene is associated with neck metastasis in oral cancer. Clinical Oral Investigations. 23(6). 2685–2694. 9 indexed citations
15.
Yang, Shun‐Fa, et al.. (2018). Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein‐9 and MAPK pathway. Environmental Toxicology. 34(1). 60–66. 17 indexed citations
16.
Su, Shih‐Chi, Chiao‐Wen Lin, Yu‐Fan Liu, et al.. (2017). Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities. Theranostics. 7(5). 1088–1099. 111 indexed citations
17.
Su, Chun‐Wen, et al.. (2016). Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression. International Journal of Medical Sciences. 14(1). 37–44. 26 indexed citations
18.
Cheng, Hsin-Lin, Yu‐Fan Liu, Chun‐Wen Su, et al.. (2016). Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk. Oncotarget. 7(43). 69384–69396. 25 indexed citations
19.
Su, Chun‐Wen, et al.. (2015). Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3. Medicine. 94(46). e2092–e2092. 29 indexed citations
20.
Lu, Ko‐Hsiu, Hui‐Wen Yang, Chun‐Wen Su, et al.. (2012). Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways. Food and Chemical Toxicology. 52. 193–199. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026